World Cancer Day reminds us that cancer is more than a statistic — behind every diagnosis is a unique human story. Together, we are UnitedByUnique, working toward more people-centred care and better outcomes for patients worldwide.
With nearly 20 million new cancer cases in 2022 — and projections reaching ~35 million by 2050 *— accelerating early-stage oncology research has never been more important.
At Biokinetica, oncology is one of our core therapeutic areas. Through Phase 1 cancer clinical trials, biosimilars, and complex early-phase development, we support first-in-human oncology programs — helping bring innovative therapies to patients faster and more safely.
Because we care.
